Related references
Note: Only part of the references are listed.Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer
Arul E. Suthananthan et al.
ANZ JOURNAL OF SURGERY (2018)
The protective activity of mesothelial cells against peritoneal growth of gastrointestinal tumors: The role of soluble ICAM-1
Justyna Mikula-Pietrasik et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression
Ying Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
The histophysiology and pathophysiology of the peritoneum
J. O. A. M. van Baal et al.
TISSUE & CELL (2017)
The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer
Valentina Mele et al.
ONCOTARGET (2017)
Clinicopathological Factors Associated with Recurrence and Prognosis after R0 Resection for Stage IV Colorectal Cancer with Peritoneal Metastasis
Harunobu Sato et al.
DIGESTIVE SURGERY (2016)
Mesothelial cells and peritoneal homeostasis
Steven Eugene Mutsaers et al.
FERTILITY AND STERILITY (2016)
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum
Lieselotte Lemoine et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Prognostic significance of CD168 overexpression in colorectal cancer
Ke Wang et al.
ONCOLOGY LETTERS (2016)
RHAMM splice variants confer radiosensitivity in human breast cancer cell lines
Alexandra Schuetze et al.
ONCOTARGET (2016)
First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors
C. Willemien Menke-van der Houven van Oordt et al.
ONCOTARGET (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers
Viktor Hendrik Koelzer et al.
HUMAN PATHOLOGY (2015)
The metastasis suppressor, NDRG1, inhibits stemness of colorectal cancer via down-regulation of nuclear β-catenin and CD44
Xiongzhi Wangpu et al.
ONCOTARGET (2015)
Mesothelial cells in tissue repair and fibrosis
Steven E. Mutsaers et al.
FRONTIERS IN PHARMACOLOGY (2015)
The role of CD44 in disease pathophysiology and targeted treatment
Andre R. Jordan et al.
FRONTIERS IN IMMUNOLOGY (2015)
CD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding Site
Helena Kellett-Clarke et al.
PLOS ONE (2015)
CD44-Mediated Adhesion to Hyaluronic Acid Contributes to Mechanosensing and Invasive Motility
Yushan Kim et al.
MOLECULAR CANCER RESEARCH (2014)
Activation of c-Met and Upregulation of CD44 Expression Are Associated with the Metastatic Phenotype in the Colorectal Cancer Liver Metastasis Model
Victoria A. Elliott et al.
PLOS ONE (2014)
Anatomy and physiology of the peritoneum
Simon C. Blackburn et al.
SEMINARS IN PEDIATRIC SURGERY (2014)
CD44 Expression in Intestinal Epithelium and Colorectal Cancer Is Independent of p53 Status
Jurrit Zeilstra et al.
PLOS ONE (2013)
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer
E. M. V. de Cuba et al.
VIRCHOWS ARCHIV (2012)
Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial
Peter Gibbs et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas
Alfonso M. Albanese et al.
SURGICAL AND RADIOLOGIC ANATOMY (2009)
Hyaluronan synthases: A decade-plus of novel glycosyltransferases
Paul H. Weigel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hyaluronan-dependent pericellular matrix
Stephen P. Evanko et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Inflammatory Cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers
W. M. U. van Grevenstein et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
F-19848A, a novel inhibitor of hyaluronic acid binding to cellular receptor CD44
Yuki Hirota-Takahata et al.
JOURNAL OF ANTIBIOTICS (2007)
F-16438s, novel binding inhibitors of CD44 and hyaluronic acid - II. Producing organism, fermentation, isolation, physico-chemical properties and structural elucidation
Yuki Hirota-Takahata et al.
JOURNAL OF ANTIBIOTICS (2006)
ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention
NA Alkhamesi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Colorectal carcinomatosis: a new oncologic frontier
PH Sugarbaker
CURRENT OPINION IN ONCOLOGY (2005)
Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction
RM Heath et al.
BRITISH JOURNAL OF CANCER (2004)
Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
VD Vazquez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Peritoneal carcinomatosis from colorectal cancer
DG Jayne et al.
BRITISH JOURNAL OF SURGERY (2002)
Mesothelial cells: Their structure, function and role in serosal repair
SE Mutsaers
RESPIROLOGY (2002)
Hyaluronan and homeostasis: A balancing act
MI Tammi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CD44-mediated uptake and degradation of hyaluronan
W Knudson et al.
MATRIX BIOLOGY (2002)
CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation
T Ahrens et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)